Healionics Corporation, a developer of synthetic biomaterial-based medical devices, announced recently that 24-month clinical ...

Okami Medical, Inc., a developer of vascular embolization solutions, announced that Drew Hykes was appointed President and ...

Imperative Care, Inc. announced late-breaking, real-world data from a multicenter review of 124 consecutive ischemic stroke ...

Pathfinder Medical, a United Kingdom-based developer of minimally invasive vascular access technologies, announced the appoint ...

In a pair of randomized, observer-blinded clinical trials designed to evaluate optimal management of asymptomatic carotid ...

Gore & Associates and Egg Medical announced findings from a national poll on the concerns regarding radiation exposure in ...

Bentley InnoMed GmbH announced CE Mark approval for the company’s BeGraft Plus for use as a bridging stent graft in bran ...

Terumo Aortic announced enrollment of the first patient in the fenestrated TREO pivotal trial in the United States. Accordi ...

Humacyte, Inc. announced that multiple presentations on the company’s acellular tissue-engineered vessel (ATEV) were del ...

AI-Stroke, a France-based Software-as-a-Medical-Device (SaMD) company using artificial intelligence (AI) to develop an “ ...

Neurotronic, Inc. announced the first clinical outcomes of the NECTAR III and NECTAR IV trials evaluating the company’s ...

RapidAI announced FDA clearance of Aortic Management, part of the company’s Rapid Aortic product, a clinical artificial ...